泰拉生物科学 TYRA
$21.15 +$0.26 (+1.24%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $21.15 0.00%
开盘$21.22
昨收$20.89
当日区间$20.75 – $21.59
成交量862.3K
市值$1.45B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$49.00M-55.8% YoY
净利润-$45.56M-62.1% YoY
摊薄每股收益-$0.69-46.8% YoY
自由现金流-$31.14M-31.3% YoY
经营现金流-$31.08M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-45.3%
资产收益率-42.2%
投入资本回报率-48.1%
流动比率14.91
负债/资产比率7.7%
现金及投资$353.94M
总负债$5.08M
净现金（净负债）$348.87M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $49.00M | $42.00M | $132.76M | $36.52M | $32.94M |
| 销售及管理费用 | $9.81M | $8.53M | $29.83M | $8.33M | $7.48M |
| -管理费用 | $9.81M | $8.53M | $29.83M | $8.33M | $7.48M |
| 研发费用 | $39.20M | $33.47M | $102.93M | $28.19M | $25.47M |
| 营业利润 | -$49.00M | -$42.00M | -$132.76M | -$36.52M | -$32.94M |
| 非经营性利息净收入（支出） | $3.45M | $2.69M | $12.82M | $2.68M | $3.08M |
| 非经营性利息收入 | $3.45M | $2.69M | $12.82M | $2.68M | $3.08M |
| 税前利润 | -$45.56M | -$39.31M | -$119.95M | -$33.83M | -$29.87M |
| 净利润 | -$45.56M | -$39.31M | -$119.95M | -$33.83M | -$29.87M |
| 持续经营利润 | -$45.56M | -$39.31M | -$119.95M | -$33.83M | -$29.87M |
| 归属母公司净利润 | -$45.56M | -$39.31M | -$119.95M | -$33.83M | -$29.87M |
| 归属普通股股东净利润 | -$45.56M | -$39.31M | -$119.95M | -$33.83M | -$29.87M |
| 基本每股收益 | -$0.69 | -$0.64 | -$2.01 | -$0.57 | -$0.50 |
| 摊薄每股收益 | -$0.69 | -$0.64 | -$2.01 | -$0.57 | -$0.50 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $383.36M | $412.04M | $282.61M | $282.61M | $301.85M |
| 流动资产合计 | $366.97M | $394.61M | $265.45M | $265.45M | $281.22M |
| 现金及现金等价物与短期投资 | $353.94M | $383.47M | $256.00M | $256.00M | $274.92M |
| -现金及现金等价物 | $73.84M | $84.96M | $77.39M | $77.39M | $61.95M |
| -短期投资 | $280.11M | $298.51M | $178.62M | $178.62M | $212.97M |
| 其他流动资产 | $13.02M | $11.15M | $9.45M | $9.45M | $6.29M |
| 非流动资产合计 | $16.40M | $17.43M | $17.16M | $17.16M | $20.64M |
| 固定资产净值 | $6.48M | $6.66M | $6.89M | $6.89M | $7.05M |
| -固定资产原值 | $6.48M | $6.66M | $6.89M | $6.89M | $7.05M |
| 其他非流动资产 | $9.91M | $10.77M | $10.27M | $10.27M | $13.59M |
| 负债合计 | $29.70M | $24.47M | $23.43M | $23.43M | $21.34M |
| 流动负债合计 | $24.62M | $19.26M | $18.09M | $18.09M | $15.88M |
| 应付款 | $2.33M | $3.64M | $1.18M | $1.18M | $1.99M |
| -应付账款 | $2.33M | $3.64M | $1.18M | $1.18M | $1.99M |
| 一年内应计费用 | $21.78M | $15.13M | $16.44M | $16.44M | $13.43M |
| 短期债务及融资租赁负债 | $504,000.00 | $488,000.00 | $472,000.00 | $472,000.00 | $456,000.00 |
| -一年内到期融资租赁负债 | $504,000.00 | $488,000.00 | $472,000.00 | $472,000.00 | $456,000.00 |
| 非流动负债合计 | $5.08M | $5.21M | $5.34M | $5.34M | $5.46M |
| 长期债务及融资租赁负债 | $5.08M | $5.21M | $5.34M | $5.34M | $5.46M |
| -长期融资租赁负债 | $5.08M | $5.21M | $5.34M | $5.34M | $5.46M |
| 股东权益合计 | $353.66M | $387.58M | $259.18M | $259.18M | $280.51M |
| 股东权益 | $353.66M | $387.58M | $259.18M | $259.18M | $280.51M |
| 股本 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 | $5,000.00 |
| -普通股 | $0.00 | $0.00 | $0.00 | $0.00 | $5,000.00 |
| -优先股 | $6,000.00 | $6,000.00 | $5,000.00 | $5,000.00 | $0.00 |
| 资本公积 | $810.36M | $798.03M | $630.04M | $630.04M | $617.49M |
| 留存收益 | -$456.12M | -$410.56M | -$371.26M | -$371.26M | -$337.42M |
| 不影响留存收益的损益 | -$580,000.00 | $107,000.00 | $393,000.00 | $393,000.00 | $442,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$31.08M | -$32.57M | -$95.14M | -$23.62M | -$22.38M |
| 持续经营经营活动现金流净额 | -$31.08M | -$32.57M | -$95.14M | -$23.62M | -$22.38M |
| 持续经营净利润 | -$45.56M | -$39.31M | -$119.95M | -$33.83M | -$29.87M |
| 折旧、折耗与摊销 | $138,000.00 | $138,000.00 | $546,000.00 | $132,000.00 | $131,000.00 |
| 营运资金变动 | $4.32M | -$1.23M | -$1.63M | $2.58M | $199,000.00 |
| -预付资产变动 | -$1.02M | -$2.44M | -$5.08M | $404,000.00 | -$1.89M |
| -应付账款及应计费用变动 | $5.32M | $1.20M | $3.37M | $2.16M | $2.07M |
| -其他营运资金变动 | $17,000.00 | $17,000.00 | $83,000.00 | $17,000.00 | $19,000.00 |
| 投资活动现金流净额 | $17.85M | -$120.24M | $72.46M | $34.38M | -$14.81M |
| 持续经营投资活动现金流净额 | $17.85M | -$120.24M | $72.46M | $34.38M | -$14.81M |
| 固定资产购置及出售净额 | -$66,000.00 | -$88,000.00 | -$141,000.00 | -$57,000.00 | -$39,000.00 |
| 投资购置及出售净额 | $17.92M | -$120.16M | $72.60M | $34.43M | -$14.77M |
| 筹资活动现金流 | $2.10M | $160.38M | $8.10M | $4.68M | $647,000.00 |
| 持续经营筹资活动现金流净额 | $2.10M | $160.38M | $8.10M | $4.68M | $647,000.00 |
| 普通股发行净额 | $0.00 | $147.85M | $0.00 | $0.00 | $0.00 |
| 股票期权行使所得 | $2.10M | $12.53M | $8.10M | $4.68M | $647,000.00 |
| 期末现金余额 | $74.84M | $85.96M | $78.39M | $78.39M | $62.95M |
| 现金净变动 | -$11.12M | $7.57M | -$14.58M | $15.44M | -$36.54M |
| 期初现金余额 | $85.96M | $78.39M | $92.97M | $62.95M | $99.49M |
| 自由现金流 | -$31.14M | -$32.66M | -$95.28M | -$23.68M | -$22.42M |
暂无评论——快来第一个聊聊 TYRA。